Insulet | PODD - Stock


Insulet reported $452.6M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Align Technology USD 228.16M 15.59M Sep/2025
AtriCure USD 78.49M 459K Dec/2025
Avanos Medical USD 148M 2.6M Dec/2025
Baxter International USD 2.23B 228M Dec/2025
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Boston Scientific USD 2.94B 22M Dec/2025
Cardinal Health USD 20.12B 2.56B Dec/2025
Cooper Companies USD 881M 252.3M Jun/2025
Dexcom USD 629.1M 25M Dec/2025
Edwards Lifesciences USD 1.14B 800K Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Globus Medical USD 759.28M 12.26M Dec/2025
ICU Medical USD 615.86M 6.58M Dec/2025
Inogen USD 25.08M 762K Sep/2025
Insulet USD 452.6M 6.3M Dec/2025
Integra LifeSciences USD 489.11M 23.98M Sep/2025
J&J USD 14.19B 45M Dec/2025
Masimo USD 338.6M 20.1M Sep/2025
Medtronic USD 6.16B 270M Sep/2025
Merit Medical Systems USD 333.7M 7.15M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Solventum Corp USD 1.05B 87M Sep/2025
Stryker USD 5.31B 60M Dec/2025
Tandem Diabetes Care USD 128.77M 8.51M Dec/2025
Teleflex USD 802.46M 108.78M Sep/2025
West Pharmaceutical Services USD 443.9M 5.9M Dec/2025
Zimmer Biomet Holdings USD 2.29B 197.3M Dec/2025